“…Significant progress in creating improved melanoma models has been made [ 76 ]. A repertoire of 3D in vitro models, such as spheroids [ 77 ] organoids [ 78 , 79 , 80 ], microfluidic platforms [ 81 ], human skin equivalents (HSEs) [ 50 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 ], and bioprinting [ 1 , 83 , 86 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 ] have been developed or have the potential to be used for the investigation of melanoma. Combinatorial strategies based on the principles of tissue engineering and bioprinting technologies are emerging as a viable route to creating biomimetic platforms for disease modelling.…”